Key Market Indicators
Belgian sales of hypnotic and sedative medicines are projected to reach almost $87 million by 2026. This is a slight increase from $89 million in 2021, representing a 0.2% year-on-year average growth since 2007. Belgium ranked fourth in 2021 in terms of hypnotic and sedative medicine sales. Sweden was in first place with $89 million, followed by Germany and Sweden in second and third place respectively.